scholarly journals Editorial Comment to Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy

2020 ◽  
Vol 3 (6) ◽  
pp. 274-274
Author(s):  
Shuya Kandori
2020 ◽  
Vol 3 (6) ◽  
pp. 270-273 ◽  
Author(s):  
Akinaru Yamamoto ◽  
Yasutomo Nakai ◽  
Toshiki Oka ◽  
Tomohiro Kanaki ◽  
Yoshiyuki Yamamoto ◽  
...  

2015 ◽  
Vol 24 (3) ◽  
pp. 379-382
Author(s):  
Tadahisa Inoue ◽  
Hitoshi Sano ◽  
Takashi Mizushima ◽  
Hirotada Nishie ◽  
Hiroyasu Iwasaki ◽  
...  

We present the case of a Japanese man in his 60s with duodenal neuroendocrine carcinoma with distant metastases. Chemotherapy with irinotecan plus cisplatin was initiated as a first-line regimen. However, disease progression was observed after only two cycles. Therefore, amrubicin was administered as a second-line chemotherapy. The patient showed a long-term effect of amrubicin therapy, and the best response was a partial response after seven cycles. For duodenal neuroendocrine carcinoma, amrubicin therapy can be considered an effective treatment option as salvage chemotherapy.


2020 ◽  
Author(s):  
Angela Lamarca ◽  
Daniel Palmer ◽  
Harpreet Wasan ◽  
Paul J. Ross ◽  
Yuk Ting Ma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document